315 Is it safe to immediately initiate adjuvant intraperitoneal chemotherapy following bowel resection in patients with newly diagnosed advanced ovarian cancer? | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article info

E-Poster viewings

Ovarian Cancer

IGCS19-0306

315 Is it safe to immediately initiate adjuvant intraperitoneal chemotherapy following bowel resection in patients with newly diagnosed advanced ovarian cancer?

Free

Authors

A Nica 1University of Toronto, Obstetrics and Gynecology- Division of Gynecologic Oncology, Toronto, Canada PubMed articles Google scholar articles
A Covens 2University of Toronto, Obstetrics and Gynecology – Division of Gynecologic Oncology – Sunnybrook Health Sciences Centre, Toronto, Canada PubMed articles Google scholar articles
T May 3University of Toronto, Obstetrics and Gynecology- Division of Gynecologic Oncology – Princess Margaret Hospital, Toronto, Canada PubMed articles Google scholar articles

Citation

Nica A, Covens A, May T

315 Is it safe to immediately initiate adjuvant intraperitoneal chemotherapy following bowel resection in patients with newly diagnosed advanced ovarian cancer?

International Journal of Gynecologic Cancer 2019;29:A131.

Publication history

First published September 18, 2019.

Online issue publication

September 18, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.